Could a diabetes drug ease pressure on the brain? new trial aims to find out.
NCT ID NCT07191873
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tests whether tirzepatide, a drug used for diabetes, can lower high brain pressure in people with idiopathic intracranial hypertension (IIH). Sixty adults with IIH will receive either tirzepatide or a placebo for 12 months. The main goal is to see if the drug reduces pressure measured by a spinal tap, and also to check for improvements in vision and headaches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INTRACRANIAL HYPERTENSION (IIH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.